Alterations of splicing and gene expression in DMSO or 4OHT treated-IMR90 ER:HRAS G12V cells upon knockdown of SF3B1 and RBM39
RNA-seq (gene expression) · human · 48 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Samples
- 48 samples: 12 conditions, mostly with about 4 replicates eachGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE297268_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1263425 and SRA study SRP585667. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 48 samples.
How we read this: 12 replicated groups read from 48 sample titles; they account for 48 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8987285 IMR90DMSO-siNT1-1 IMR90DMSO-siNT1
- GSM8987286 IMR90DMSO-siNT1-2 IMR90DMSO-siNT1
- GSM8987287 IMR90DMSO-siNT1-3 IMR90DMSO-siNT1
- GSM8987288 IMR90DMSO-siNT1-4 IMR90DMSO-siNT1
- GSM8987289 IMR904OHT-siNT1-1 IMR904OHT-siNT1
- GSM8987290 IMR904OHT-siNT1-2 IMR904OHT-siNT1
- GSM8987291 IMR904OHT-siNT1-3 IMR904OHT-siNT1
- GSM8987292 IMR904OHT-siNT1-4 IMR904OHT-siNT1
- GSM8987293 IMR90DMSO-siNT2-1 IMR90DMSO-siNT2
- GSM8987294 IMR90DMSO-siNT2-2 IMR90DMSO-siNT2
- GSM8987295 IMR90DMSO-siNT2-3 IMR90DMSO-siNT2
- GSM8987296 IMR90DMSO-siNT2-4 IMR90DMSO-siNT2
- GSM8987297 IMR904OHT-siNT2-1 IMR904OHT-siNT2
- GSM8987298 IMR904OHT-siNT2-2 IMR904OHT-siNT2
- GSM8987299 IMR904OHT-siNT2-3 IMR904OHT-siNT2
- GSM8987300 IMR904OHT-siNT2-4 IMR904OHT-siNT2
- GSM8987301 IMR90DMSO-siSF3B1-13-1 IMR90DMSO-siSF3B1-13
- GSM8987302 IMR90DMSO-siSF3B1-13-2 IMR90DMSO-siSF3B1-13
- GSM8987303 IMR90DMSO-siSF3B1-13-3 IMR90DMSO-siSF3B1-13
- GSM8987304 IMR90DMSO-siSF3B1-13-4 IMR90DMSO-siSF3B1-13
- GSM8987305 IMR904OHT-siSF3B1-13-1 IMR904OHT-siSF3B1-13
- GSM8987306 IMR904OHT-siSF3B1-13-2 IMR904OHT-siSF3B1-13
- GSM8987307 IMR904OHT-siSF3B1-13-3 IMR904OHT-siSF3B1-13
- GSM8987308 IMR904OHT-siSF3B1-13-4 IMR904OHT-siSF3B1-13
- GSM8987309 IMR90DMSO-siSF3B1-16-1 IMR90DMSO-siSF3B1-16
- GSM8987310 IMR90DMSO-siSF3B1-16-2 IMR90DMSO-siSF3B1-16
- GSM8987311 IMR90DMSO-siSF3B1-16-3 IMR90DMSO-siSF3B1-16
- GSM8987312 IMR90DMSO-siSF3B1-16-4 IMR90DMSO-siSF3B1-16
- GSM8987313 IMR904OHT-siSF3B1-16-1 IMR904OHT-siSF3B1-16
- GSM8987314 IMR904OHT-siSF3B1-16-2 IMR904OHT-siSF3B1-16
- GSM8987315 IMR904OHT-siSF3B1-16-3 IMR904OHT-siSF3B1-16
- GSM8987316 IMR904OHT-siSF3B1-16-4 IMR904OHT-siSF3B1-16
- GSM8987317 IMR90DMSO-siRBM39-06-1 IMR90DMSO-siRBM39-06
- GSM8987318 IMR90DMSO-siRBM39-06-2 IMR90DMSO-siRBM39-06
- GSM8987319 IMR90DMSO-siRBM39-06-3 IMR90DMSO-siRBM39-06
- GSM8987320 IMR90DMSO-siRBM39-06-4 IMR90DMSO-siRBM39-06
- GSM8987321 IMR904OHT-siRBM39-06-1 IMR904OHT-siRBM39-06
- GSM8987322 IMR904OHT-siRBM39-06-2 IMR904OHT-siRBM39-06
- GSM8987323 IMR904OHT-siRBM39-06-3 IMR904OHT-siRBM39-06
- GSM8987324 IMR904OHT-siRBM39-06-4 IMR904OHT-siRBM39-06
+ 8 more — browse all 48 samples with per-sample file links →
- GSE209624 Alterations of splicing and gene expression in IMR90 Control cells and IMR90 RAS cells upon knockdown of SF3B1. 24 samples shares sf3b1, alterations
- GSE251915 Eradicating neuroblastomas by an RBM39 degrader in combination with anti-GD2 immunotherapy regardless of cancer cell state alterations [CUT&Tag] 10 samples shares rbm39, alterations
- GSE255179 Altered RNA export by SF3B1 mutants confers sensitivity to nuclear export inhibition 92 samples shares sf3b1
- GSE278154 Bulk and single cell RNA sequencing analyses of GBM Primary and Recurrent, early and late passages, DMSO / TMZ treatment. 37 samples shares dmso
- GSE301583 Polysome seq of treated with Enzalutamide and untreated (DMSO)prostate cancer cell line with SPEN wt and SPEN KO 30 samples shares dmso
- GSE304350 Distinct and convergent effects of SF3B1 mutations in human breast cancer 30 samples shares sf3b1
- GSE227343 E7820, an Anti-Cancer Sulfonamide, Degrades RBM39 in Patients with Splicing Factor Mutant Myeloid Malignancies: A Phase II Clinical Trial 29 samples shares rbm39
- GSE22917 SAGE-Seq gene expression profiles of Hs578T, MCF7, and SUM159PT cells treated with STAT3 or non-targeting siRNAs, DMSO, or CXCR2, PTGIS, HAS1, PFKFB3, JAK, or NQO1 inhibitor 27 samples shares dmso
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.